Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Corpus Christi › NPI 1588738389
Clinic

Women's and Men's Health Services of the Coastal Bend, INC.

Women's and Men's Health Services of the Coastal Bend, INC. was paid $4.36M by Medicaid between Jan 2018 and Dec 2024, across 48 billing codes. Its largest line is S4993, Contraceptive pills for birth control — 22% of everything it billed.

33Billing provider infoWOMEN'S AND MEN'S HEALTH SERVICES OF THE COASTAL BEND, INC.
CORPUS CHRISTI, TX 78415
33aNPI1588738389assigned 11/20/2006
28Total paid$4.36M
24GClaims169,218
24DCodes billed48
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Non-Surgical Family Planning Clinic/Center providers in Texas

Rank by total paid#2 of 20
Median peer was paid$5K
This provider vs. median808×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,721$9K
20191,769$10K
202028,626$891K
202147,449$1.35M
202239,646$1.04M
202331,265$737K
2024incomplete18,742$324K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
S4993 Contraceptive pills for birth control 22% 6,731 6,433 $960K
J1050 Injection, medroxyprogesterone acetate, 1 mg 12% 7,515 7,375 $510K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies 10% 596 580 $438K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 9.0% 5,917 5,893 $394K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8.7% 13,884 12,910 $380K
J7295 Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each 3.7% 120 113 $160K
J7303 Contraceptive supply, hormone containing vaginal ring, each 3.6% 100 100 $158K
81025 3.6% 23,166 22,070 $157K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.5% 4,242 4,103 $150K
99385 2.8% 1,663 1,646 $123K
A4267 Contraceptive supply, condom, male, each 2.6% 44,194 39,330 $113K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2.3% 1,680 1,622 $98K
36 more codes
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.2% 8,477 $97K
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening 2.2% 6,578 $95K
99000 1.6% 6,852 $68K
87210 1.4% 13,561 $62K
11982 1.3% 540 $55K
57454 1.2% 628 $52K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 3,376 $36K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 495 $36K
90651 <1% 125 $27K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,446 $26K
11981 <1% 295 $24K
A4269 Contraceptive supply, spermicide (e.g., foam, gel), each <1% 1,371 $19K
A9150 Non-prescription drugs <1% 1,300 $18K
81002 <1% 6,280 $17K
J3490 Unclassified drugs <1% 491 $17K
J7304 Contraceptive supply, hormone containing patch, each <1% 53 $14K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 429 $13K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,405 $7K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,405 $7K
11983 <1% 25 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 729 $4K
58301 <1% 60 $4K
99201 <1% 116 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 353 $2K
58300 <1% 26 $2K
99406 <1% 533 $1K
J0558 Injection, penicillin g benzathine and penicillin g procaine, 100,000 units <1% 89 $703.56
0012A <1% 18 $640.00
85018 <1% 191 $364.36
87510 <1% 102 $286.28
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 64 $80.92
88142 <1% 120 $51.06
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 161 $14.97
86592 <1% 65 $7.18
S5000 Prescription drug, generic 0% 1,623 $0.00
87660 0% 28 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSTUKENBERG, AMANDA (EXECUTIVE DIRECTOR)
Same official

Other billing entities under STUKENBERG, AMANDA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.